These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


441 related items for PubMed ID: 27979961

  • 101.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 102.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 103.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 104.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 105. Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?
    Colafigli G, Scalzulli E, Di Prima A, Pepe S, Loglisci MG, Diverio D, Martelli M, Foà R, Breccia M.
    Crit Rev Oncol Hematol; 2021 Jan; 157():103163. PubMed ID: 33246263
    [Abstract] [Full Text] [Related]

  • 106. A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.
    García-Gutiérrez V, Gómez-Casares MT, Puerta JM, Alonso-Domínguez JM, Osorio S, Hernández-Boluda JC, Collado R, Ramírez MJ, Ibáñez F, Martín ML, Rodríguez-Gambarte JD, Martínez-Laperche C, Gómez M, Fiallo DV, Redondo S, Rodríguez A, Ruiz-Nuño C, Steegmann JL, Jiménez-Velasco A, Spanish Group of Chronic Myeloid Leukemia (GELMC).
    PLoS One; 2017 Jan; 12(3):e0173532. PubMed ID: 28278193
    [Abstract] [Full Text] [Related]

  • 107.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 108.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 109.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 110. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
    Stock W, Yu D, Karrison T, Sher D, Stone RM, Larson RA, Bloomfield CD.
    Int J Oncol; 2006 May; 28(5):1099-103. PubMed ID: 16596225
    [Abstract] [Full Text] [Related]

  • 111.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 112. [Comparison of BCR::ABL (P210) mRNA levels detected by dPCR and qPCR methods in patients with chronic myeloid leukemia].
    Gao HL, Hao Y, Chen WM, Li LD, Wang X, Qin YZ, Jiang Q.
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov 14; 44(11):906-910. PubMed ID: 38185519
    [Abstract] [Full Text] [Related]

  • 113.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 114.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 115.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 116.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 117.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 118.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 119. Low prevalence of the BCR-ABL1 fusion gene in a normal population in southern Sarawak.
    Kuan JW, Su AT, Tay SP, Fong IL, Kubota S, Su'ut L, Osato M, Sashida G.
    Int J Hematol; 2020 Feb 14; 111(2):217-224. PubMed ID: 31707540
    [Abstract] [Full Text] [Related]

  • 120. Optimized Digital Droplet PCR for BCR-ABL.
    Maier J, Lange T, Cross M, Wildenberger K, Niederwieser D, Franke GN.
    J Mol Diagn; 2019 Jan 14; 21(1):27-37. PubMed ID: 30347270
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.